{"database": "openregs", "table": "documents", "rows": [["FDA-2023-N-0061-0002", "FDA", "FDA-2023-N-0061", "Reference Summary List for Drug Products or Categories of Drug Products That Present Demonstrable Difficulties for Compounding Under sections 503A and 503B", "Supporting & Related Material", "Background Material", "2024-03-20T04:00:00Z", 2024, 3, null, null, "2024-03-20T15:34:54Z", null, 0, 0, "0900006486487b7b"]], "columns": ["id", "agency_id", "docket_id", "title", "document_type", "subtype", "posted_date", "posted_year", "posted_month", "comment_start_date", "comment_end_date", "last_modified", "fr_doc_num", "open_for_comment", "withdrawn", "object_id"], "primary_keys": ["id"], "primary_key_values": ["FDA-2023-N-0061-0002"], "units": {}, "query_ms": 26.427699020132422, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}